Fostemsavir en adultos con infección por VIH-1 resistente a múltiples fármacos (03-06-2020)

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression (20-05-2020)

VI Jornadas Docentes de GeSIDA

Fecha de inicio y cierre del curso:
Madrid  los días 25 y 26 de Septiembre  de 2020
VIH, GLOBALIZACIÓN Y MIGRACIÓN

Descargar Convocatoria
Descargar Formulario de Solicitud

Descargar Programa

Accede a las Jornadas

Sex Differences in People Aging with HIV (30-04-2020)

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) maintains HIV-1 virologic suppression through 48 weeks: results of the DRIVE-SHIFT trial. (15-04-2020)

Webinar GeSIDA sobre COVID-19 Y VIH

Presentaciones: ver

Incidence and Risk Factors for Invasive Pneumococcal Disease and Communityacquired Pneumonia in Human Immunodeficiency Virus–Infected Individuals in a High-income SeBng (01-04-2020)

On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. (13-03-2020)

Comorbidity and polypharmacy among women living with HIV in British Columbia (28-02-2020)

Prevalence and incidence of HPV infection in men having sex with men enrolled in a PrEP study: A sub-study of the ANRS IPERGAY trial. (14-02-2020)